 |
|
Medication Therapy Management and Cost-Related Medication Nonadherence—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: We agree with Drs Guirguis and Zingone that medication therapy management, an unmeasurable variable in our study, may play an important role in reducing medication nonadherence among enrollees in Medicare drug plans. Despite the encouraging results of a small randomized controlled trial of the effects of an innovative face-to-face pharmacy care program on adherence and blood pressure among elderly persons,1 more study of the cost-effectiveness of this model is needed to justify nationwide implementation. For example, it is important to know whether the results of such intensive face-to-face clinical pharmacy services can be generalized from an academic medical center to large community populations and how such a program would be organized. Once Part D data are available, the Centers for Medicare & Medicaid Services should fund studies evaluating benefits and costs of alternative medication therapy management interventions in Part D plans (eg, face-to-face vs impersonal approaches) to inform . . . [Full Text of this Article]
Stephen B. Soumerai, ScD;
Jeanne Madden, PhD
jeanne_madden@harvardpilgrim.org
Department of Ambulatory Care and Prevention
Harvard Medical School
Boston, Massachusetts
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Medication Therapy Management and Cost-Related Medication Nonadherence
Alexander B. Guirguis and Michelle M. Zingone
JAMA. 2008;300(10):1130.
EXTRACT
| FULL TEXT
Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Controlled Trial
Jeannie K. Lee, Karen A. Grace, and Allen J. Taylor
JAMA. 2006;296(21):2563-2571.
ABSTRACT
| FULL TEXT
|
